You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
長春高新(000661.SZ):生長激素產品今年4-5月純銷綜合來看仍有20%左右增長
格隆匯 06-08 10:19

格隆匯6月8日丨長春高新(000661.SZ)於2023年6月7日19:00-21:30召開電話會議,就近期經營情況,公司表示,雖然二季度對於公司核心產品的銷售相對來説屬於淡季,但從近期經營情況來看,公司市場恢復趨勢良好。受去年同期疫情影響,5月份生長激素產品新患、純銷環比增幅略有收窄,但鑑於去年市場的特殊性,將4、5兩個月份的相關數據進行同比才具有科學性。4、5月份新患同比增長40%左右,在純銷方面,去年4月份曾局部出現供貨短期中斷的情況,使得去年5月份部分患者集中購買藥品,導致該月份出現純銷體量相對來説略大的情況,但今年4-5月純銷綜合來看仍有20%左右增長。

對於金賽藥業相關新業務板塊,部分業務板塊新負責人已經入職,同時公司穩步推進新業務板塊相關經營、規劃工作。

目前新上市的胃佔容食品初步上市推廣情況良好;從相關方取得所有權的利丙雙卡因乳膏(金賽寧),相關方部分劑型已獲國家藥監局批准上市。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account